Influential Factors of Clinical Outcome of Local Intra-Arterial Thrombolysis using Urokinase in Patients with Hyperacute Ischemic Stroke.
10.3348/jkrs.2002.47.4.343
- Author:
Jae Min SONG
1
;
Woong YOON
;
Jae Kyu KIM
;
Jeong Jin SEO
;
Sook Hee HEO
;
Jin Gyoon PARK
;
Yong Yeon JEONG
;
Heoung Keun KANG
Author Information
1. Department of Diagnostic Radiology, Chonnam University Hospital. jjseo@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Brain, ischemia;
Brain, blood flow;
Thrombolysis;
Urokinase
- MeSH:
Angiography;
Carotid Artery, Internal;
Fatal Outcome;
Hemorrhage;
Humans;
Middle Cerebral Artery;
National Institutes of Health (U.S.);
Stroke*;
Urokinase-Type Plasminogen Activator*
- From:Journal of the Korean Radiological Society
2002;47(4):343-350
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the clinical outcome and other relevant factors in cases where local intra-aterial thrombolysis (LIT) is used for the threatment of hyperacute ischemic stroke. MATERIALS AND METHODS: Forty-eight hyperacute ischemic stroke patients were treated by LIT, using urokinase, within six hours of ictus, and for evaluation of their neurological status, the National Institutes of Health Stroke Scale (NIHSS) score was used. Angiographic recanalization was classified according to Mori recanalization grades. Three months after LIT, the outcome was assessed by clinical examination using the modified Rankin scale (good outcome: RS=0-3; poor outcome: RS=4-6). In all patients, the findings of pre- and post- LIT CT, and angiography, as well as neurological status and hemorrhagic complications, were also analysed. RESULTS: Thirty-three patients had occlusions of the middle cerebral artery (MCA), and 15, of the internal carotid artery (ICA). The NIHSS score averaged 16.9 at the onset of therapy and 13.5 at 24 hours later. Successful recanalization (Mori grade 3,4) was achieved in 28 (58.3%) of 48 patients, but in 20 (41.7%) the attempt failed. Twenty-two (45.8%) of the 48 patients had a good outcome, but in (54.2%) the outcome was poor. Thirteen (40.6%) of 32 patients with MCA occlusions and 13 (81.2%) of 16 with ICA occlusions had a poor outcome. Eight patients (16.7%) died. Overall, hemorrhages occured in 20 (41.7%) of 48 patients, with symptomatic hemorrhage in ten. Five (50%) of these ten died. CONCLUSION: LIT using urokinase for hyperacute ischemic stroke is feasible; patients with MCA occlusions had better outcomes than those with ICA occlusions. Hemorrhagic complications of LIT were frequent, and in cases of symptomatic hemorrhage a fatal outcome may be expected.
